AK Medical: Take It If The Answers Are Good
AK Medical Holdings (1789 HK) is a new listing with a proposed price range of HKD1.66 -2.00. The company is China's leading (in volume) orthopedic...
633 Views
Smith & Nephew - No distractions from the search for growth
Smith & Nephew's Q317 results featured 9% revenue growth in emerging markets that continued the trend of previous quarters. A further...
85 Views
Continuing to focus on execution
Smith & Nephew's Q117 demonstrated a return to double-digit growth in emerging markets, with China growing 14% in the quarter. Alongside...
87 Views
All parts now in place to move forward
Smith & Nephew (S&N) delivered a fair Q4 and FY16, which were affected by tough market conditions in China and the Gulf states. However,...
87 Views
Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
AML represents one of the largest hematologic cancer populations with one of the worst survival rates. Global prevalence is expected to increase at...
521 Views